Terbium-161 for PSMA-Targeted Radionuclide Therapy of Prostate Cancer

被引：0
|
作者：
Mueller, C. [1 ]
Umbricht, C. A. [1 ]
Gracheva, N. [1 ]
Tschan, V. J. [1 ]
Pellegrini, G. [2 ]
Bernhardt, P. [3 ]
Zeevaart, J. R. [4 ]
Koester, U. [5 ]
Schibli, R. [1 ]
van der Meulen, N. P. [1 ]
机构：
[1] Paul Scherrer Inst, Villigen, Switzerland
[2] Univ Zurich, Vetsuisse Fac, Zurich, Switzerland
[3] Univ Gothenburg, Gothenburg, Sweden
[4] Necsa, Pretoria, South Africa
[5] Insitut Laue Langevin, Grenoble, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2018年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-164
引用
收藏
页码：S53 / S54
页数：2
相关论文
共 50 条
  • [21] A PSMA-Targeted Theranostic Agent for Prostate Cancer
    Chen, Ying
    Pullambhatla, Mrudula
    Minn, Il
    Wang, Yuchuan
    Jin, Jiefu
    Bhujwalla, Zaver
    Mease, Ronnie
    Pomper, Martin
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [22] PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617
    Kratochwil, Clemens
    Giesel, Frederik L.
    Stefanova, Melsa
    Benesova, Martina
    Bronzel, Marcus
    Afshar-Oromieh, Ali
    Mier, Walter
    Eder, Matthias
    Kopka, Klaus
    Haberkorn, Uwe
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (08) : 1170 - 1176
  • [23] PSMA-targeted therapy for non-prostate cancers
    Wang, Jarey H.
    Kiess, Ana P.
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [24] PSMA-targeted radioligand therapy in prostate cancer: current status and future prospects
    Parghane, Rahul, V
    Basu, Sandip
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (09) : 959 - 975
  • [25] PSMA-Targeted Nanotheranostics for Imaging and Radiotherapy of Prostate Cancer
    Meher, Niranjan
    VanBrocklin, Henry E. F.
    Wilson, David M. M.
    Flavell, Robert R. R.
    [J]. PHARMACEUTICALS, 2023, 16 (02)
  • [26] Value proposition of PSMA-targeted α–particle radioligand therapy in metastatic prostate cancer
    Hossein Jadvar
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 8 - 10
  • [27] The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research
    Ruigrok, Eline A. M.
    van Weerden, Wytske M.
    Nonnekens, Julie
    de Jong, Marion
    [J]. PHARMACEUTICS, 2019, 11 (11)
  • [28] Value proposition of PSMA-targeted α-particle radioligand therapy in metastatic prostate cancer
    Jadvar, Hossein
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (01) : 8 - 10
  • [29] PSMA-targeted photodynamic therapy in surgical prostate tumor samples
    Derks, Y.
    Schilham, M.
    van Lith, S.
    Sedelaar, M.
    Somford, D.
    Gotthardt, M.
    Lowik, D.
    Lutje, S.
    Heskamp, S.
    Rijpkema, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S315 - S315
  • [30] Development of Terbium-161 Based VLA-4 Targeted Theranostics
    Iweha, Ejike
    Bellavia, Michael
    Bokolo, Patrick
    Keys, Zackary
    Van Ho
    Pun, Michael
    Serasinghe, Madhushan
    Gallazzi, Fabio
    Watkinson, Lisa
    Carmack, Terry
    Tatum, David
    Magda, Darren
    Hennkens, Heather
    Anderson, Carolyn
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S58 - S58
12345